Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
British Journal of Cancer|October 14, 2010
Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patientsA Abajo, J Rodriguez, N Bitarte, et al.
European Journal of Cancer (Oxford, England : 1990)|January 12, 2011
Association of RRM1 -37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapyJ Rodriguez, V Boni, A Hernández, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2019
Noncontiguous operon is a genetic organization for coordinating bacterial gene expressionS Sáenz-Lahoya, N Bitarte, B García, et al.
British Journal of Cancer|June 16, 2012
Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patientsA Abajo, V Boni, I Lopez, et al.
British Journal of Cancer|March 11, 2010
Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysisR Zarate, J Rodríguez, E Bandres, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2008
Epigenetic events in normal colonic mucosa surrounding colorectal cancer lesionsN Ramírez, E Bandrés, A Navarro, et al.
Pageof 1